目的 了解2017年吉林大学第一医院二部住院患者氧化樟脑注射液的使用情况，对用药合理性进行评价。方法 调取2017年各季度吉林大学第一医院二部氧化樟脑注射液的使用情况，并对480份使用氧化樟脑注射液的病例进行调查，对用药合理性进行评价。结果 氧化樟脑注射液4个季度的消耗情况较为稳定，其中第3季度略低。主要用药科室为心血管内科和普通外科，比例分别为64.13%、21.29%。氧化樟脑注射液适应症相符率为53.54%。给药剂量、频次及溶媒选择均较为合理。结论 氧化樟脑注射液在吉林大学第一医院二部的使用较为稳定，但使用的合理性有待于进一步规范。

Objective To analyze the clinical use of Vitacamphorae Injection in the First Hospital of Jilin University-DivisionⅡ in 2017, and to evaluate the rational use. Methods The use of Vitacamphorae Injection in the First Hospital of Jilin University-DivisionⅡ in 2017 was selected. A total of 480 patients used Vitacamphorae Injection were also investigated, and the rational drug use was evaluated. Results The composition of Vitacamphorae Injection was relatively stable in 2017, and the composition was slightly lower in the third quarter. The main composition was used in departments of cardiovascular medicine department and general surgery department. The proportion was 64.13% and 21.29%, respectively. The dose, frequency, and solvent were reasonable, however, the indication rate was 53.54%.Conclusion The use of Vitacamphorae Injection in the First Hospital of Jilin University-DivisionⅡ is stable, but the use of rationality should be further standardized.